2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow ioflupane: new trials by email Literature Review of ioflupane trials Research Report on ioflupane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers. DaTSCAN™ Ioflupane (123I) Injection - Healthy Subjects (HS) | Phase 1 | Completed | GE Healthcare | 9 | 2021-05-13 | 2023-08-02 |
| Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls (11C)PE2I, Ioflupane - Parkinson Disease, REM Sleep Behavior Disorder | Phase 1 / Phase 2 | Completed | Weill Medical College of Cornell University | 82 | 2018-08-14 | 2025-03-12 |
Parkinson Disease (1) · REM Sleep Behavior Disorder (1)
GE Healthcare (1) · Weill Medical College of Cornell University (1)
China (1) · United States (1)
Alexander Shtilbans, MD (1) · Biao LI (1)
R01NS095562 (1)